BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35163398)

  • 1. ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro.
    Gamallat Y; Zaaluk H; Kish EK; Abdelsalam R; Liosis K; Ghosh S; Bismar TA
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.
    Maynard JP; Lu J; Vidal I; Hicks J; Mummert L; Ali T; Kempski R; Carter AM; Sosa RY; Peiffer LB; Joshu CE; Lotan TL; De Marzo AM; Sfanos KS
    J Pathol; 2022 Feb; 256(2):149-163. PubMed ID: 34652816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.
    Li Y; Su J; DingZhang X; Zhang J; Yoshimoto M; Liu S; Bijian K; Gupta A; Squire JA; Alaoui Jamali MA; Bismar TA
    J Pathol; 2011 May; 224(1):90-100. PubMed ID: 21381033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
    Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
    Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
    Huang KC; Bégin LR; Palanisamy N; Donnelly B; Bismar TA
    Urol Oncol; 2016 May; 34(5):235.e1-10. PubMed ID: 26725250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance.
    Lokman U; Erickson AM; Vasarainen H; Rannikko AS; Mirtti T
    Eur Urol Focus; 2018 Dec; 4(6):867-873. PubMed ID: 28753869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.
    Teng LH; Wang C; Bégin LR; Dolph M; Yilmaz A; Trpkov K; Donnelly B; Bismar TA
    Urology; 2013 Aug; 82(2):394-9. PubMed ID: 23746715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The overexpression of actin related protein 2/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression
    Huang J; Zhou H; Tan C; Mo S; Liu T; Kuang Y
    Front Immunol; 2023; 14():1182677. PubMed ID: 37304283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
    Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis.
    Al Bashir S; Alshalalfa M; Hegazy SA; Dolph M; Donnelly B; Bismar TA
    J Hematol Oncol; 2014 Mar; 7():21. PubMed ID: 24606912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion.
    Huang KC; Evans A; Donnelly B; Bismar TA
    Pathol Oncol Res; 2017 Apr; 23(2):399-407. PubMed ID: 27738792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.
    Khosh Kish E; Gamallat Y; Choudhry M; Ghosh S; Seyedi S; Bismar TA
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
    Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.
    Bismar TA; Yoshimoto M; Vollmer RT; Duan Q; Firszt M; Corcos J; Squire JA
    BJU Int; 2011 Feb; 107(3):477-85. PubMed ID: 20590547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
    Guan WY; Zhao S; Luo YN
    Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERG Expression in Prostate Needle Biopsy: Potential Diagnostic and Prognostic Implications.
    Lee SL; Yu D; Wang C; Saba R; Liu S; Trpkov K; Donnelly B; Bismar TA
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):499-505. PubMed ID: 25517865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein treatment duration effects biomarkers of cell motility in human prostate.
    Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
    PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patients.
    Qi M; Yang X; Zhang F; Lin T; Sun X; Li Y; Yuan H; Ren Y; Zhang J; Qin X; Han B
    PLoS One; 2014; 9(2):e84959. PubMed ID: 24516518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR‑583 inhibits the proliferation and invasion of prostate cancer cells by targeting JAK1.
    Li Z; Chen J
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.